Higher Risk of Acute Coronary Syndrome in Patients With COPD Using 2 vs 1 Long-Acting Bronchodilators
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
BMJ Open Respiratory Research
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Is the Use of Two Versus One Long-Acting Bronchodilator by Patients With COPD Associated With a Higher Risk of Acute Coronary Syndrome in Real-World Clinical Practice?
BMJ Open Respir Res 2021 Jan 01;8(1)00, L Parkin, S Williams, D Barson, K Sharples, S Horsburgh, R Jackson, J DummerFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.